SCHEMBL845393

SCHEMBL845393

CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccn3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
MAPK10 P53779 1/20 0.45
MAPK1 P28482 2/20 0.44
PABPC1 P11940 1/20 0.44
ALDH1A1 P00352 3/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HCRTR1 O43613 2/20 0.43
HCRTR2 O43614 2/20 0.43
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
CYP3A4 P08684 1/20 0.41
EPHX2 P34913 1/20 0.41
KCNH2 Q12809 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845195 0.95 HCRTR1 (0.46) GAAMAPK1PABPC1ALDH1A1CYP2C9
SCHEMBL845286 0.91 ALDH1A1 (0.48) GAAPABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL845441 0.89 GAA (0.43) GAAMAPK1PABPC1ALDH1A1CYP2C9
SCHEMBL845154 0.85 ALDH1A1 (0.54) MAPK1PABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL845408 0.85 ALDH1A1 (0.54) MAPK1PABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL844923 0.84 ALDH1A1 (0.43) GAAMAPK10ALDH1A1CYP2C9CYP2C19
SCHEMBL845401 0.83 ALDH1A1 (0.45) MAPK10ALDH1A1CYP2C9CYP2C19HCRTR1
SCHEMBL845304 0.80 MAPK1 (0.52) MAPK1ALDH1A1CYP2C9CYP2C19HTT
SCHEMBL845086 0.80 EPHX2 (0.40) ALDH1A1KDM4ECYP3A4EPHX2MEN1
SCHEMBL845391 0.80 GAA (0.42) GAAMAPK1PABPC1ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed